PJP:ARCA-PowerShares Dynamic Pharmaceuticals (USD)

ETF | Health | NYSE Arca

Last Closing

USD 85.4903

Change

-1.04 (-1.21)%

Market Cap

USD 0.91B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 23 U.S. pharmaceuticals companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Inception Date: 23/06/2005

Primary Benchmark: Dynamic Pharmaceutical Intellidex TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.57%

Management Expense Ratio: 0.56 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-02 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

N/A

USD 42.49B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

N/A

USD 3.19B
FXH First Trust Health Care AlphaD.. 0.63 %

N/A

USD 1.30B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

N/A

USD 0.23B
IDNA iShares Genomics Immunology an.. 0.00 %

N/A

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF 0.50 %

N/A

USD 0.11B
XHS SPDR® S&P Health Care Service.. 0.35 %

N/A

USD 0.09B
HTEC Robo Global® Healthcare Techn.. 0.00 %

N/A

USD 0.06B
BBP Virtus LifeSci Biotech Product.. 0.79 %

N/A

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

N/A

USD 0.01B

ETFs Containing PJP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.34% 100% F 80% B-
Dividend Return 0.50% 60% D- 11% F
Total Return 12.84% 100% F 77% C+
Trailing 12 Months  
Capital Gain 9.32% 43% F 63% D
Dividend Return 0.99% 56% F 12% F
Total Return 10.31% 48% F 55% F
Trailing 5 Years  
Capital Gain 48.14% 67% D+ 73% C
Dividend Return 4.05% 56% F 12% F
Total Return 52.19% 67% D+ 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 6.68% 48% F 62% D
Dividend Return 7.27% 52% F 56% F
Total Return 0.59% 58% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 12.94% 67% D+ 69% C-
Risk Adjusted Return 56.22% 67% D+ 75% C
Market Capitalization 0.91B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike